✦ LIBER ✦

The Budget Impact of Introducing Bg-12 (Dimethyl Fumarate) for Treatment of Relapse-Remitting Multiple Sclerosis (RRMS) in Canada

✍ Scribed by Dorman, E.; Kansal, A.R.; Sarda, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Cost Effectiveness of BG-12 (Dimethy

✍ Su, W.; Walker, A.; Sarda, S.; Kansal, A.R.; Vicente, C.; Deniz, B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Dimethyl fumarate (BG-12) for the treatm

✍ Stangel, Martin; Linker, Ralf A 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 927 KB

Oral BG-12 (dimethyl fumarate) for relap

✍ Havrdova, Eva; Hutchinson, Michael; Kurukulasuriya, Nuwan C; Raghupathi, Kartik; 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 661 KB

Clinical efficacy of BG-12 (dimethyl fum

✍ Hutchinson, Michael; Fox, Robert J.; Miller, David H.; Phillips, J. Theodore; Ki 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 398 KB

Clinical efficacy of BG-12 (dimethyl fum

✍ Bar-Or, Amit; Gold, Ralf; Kappos, Ludwig; Arnold, Douglas L.; Giovannoni, Gavin; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 351 KB

Safety and tolerability of BG-12 (dimeth

✍ Selmaj, K.; Phillips, J.T.; Fox, R.J.; Raghupathi, K.; Yuan, H.; Novas, M.; Swee 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 80 KB